ONCAlert | Upfront Therapy for mRCC
Bladder Cancer: Articles
Pembrolizumab Granted Priority Review for Treatment of Patients With NMIBC
3:15 PM, Mon December 2, 2019
Sitravatinib Plus Nivolumab Induces Responses in Patients With Metastatic Urothelial Carcinoma
6:56 PM, Wed November 27, 2019
Synergism of Immune Checkpoint Inhibitors and Antibody-Drug Conjugates Induce Promising Response Rates
7:05 PM, Thu November 21, 2019
Sacituzumab Govitecan Induced Responses in Pretreated Metastatic Urothelial Carcinoma
6:36 PM, Wed November 13, 2019
Novel Agents Influence the Development of New Strategies for Treatment of Bladder Cancer
7:53 PM, Fri November 1, 2019
ESMO Issues Practice Guidelines Update for Treatment of Bladder Cancer
5:08 PM, Tue October 29, 2019
Atezolizumab and Chemotherapy Prolongs Survival in Locally Advanced or Metastatic UC
8:32 PM, Fri October 25, 2019
Expert Discusses Challenges With Checkpoint Inhibition in the Frontline Treatment of Metastatic Bladder Cancer
8:00 PM, Wed October 2, 2019
